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Abstract
Respiratory diseases are commonly found in children with a vitamin D deficiency. These diseases are caused by a combination of processes 
resulting from the lack of vitamin D, beginning with poor rib mineralization and thoracic deformations, followed by decreased resistance to 
infections and delayed differentiation of some pulmonary cell types.  The main arguments for the immunomodulatory properties of 1.25(OH)2D3 
are: 1) the detection of fermented 25(OH) D-1α-hydroxylase and VDR in immune system cells, 2) the prevention of autoimmune diseases in 
laboratory animals with the aid of hormone D and its analogues, 3) VDR activation by hormone-D, hindering gene activity and cellular immunity 
factors such as interleukin 2 (IL-2), coloniostimulator factor granulocyte-macrophage (FCS-GM), and γ-interferon (γ - IFN).
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Витамин D  как фактор профилактики острых респираторных инфекций
Респираторные заболевания часто встречаются у детей с дефицитом витамина D.  Они представляют собой сочетание процессов, 
которые, в свою очередь, вызваны недостаточностью витамина Д: деффективная минерализации реберного каркаса грудной клетки, а 
также низкая сопротивляемость инфекциям и задержка дифференциации некоторых типов легочных клеток.  Главными аргументами в 
пользу иммуномодулирующих свойств 1α25(OH)2D3 выступают: 1) обнаружение ферментера 25(OH)D-1α-гидроксилазы и рецепторов 
к витамину D (РВД) в клетках иммунной системы; 2) предотвращение с помощью гормона D и его аналогов аутоиммунных заболеваний 
у лабораторных животных; 3) активация гормоном D РВД затормаживает активность генов и клеточных факторов иммунитета, таких 
как интерлейкин-2 (ИЛ-2), гранулоцитарно-макрофагальный колониестимулирующий фактор (ГМ-КСФ), γ-интерферон (γ - ИНФ).
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Respiratory diseases are common in children with vita-
min D deficiency.  They result from a combination of processes 
caused by the lack of vitamin D: beginning with poor rib 
mineralization and thoracic deformations, and followed by 
decreased resistance to infections and delayed differentiation 
of some pulmonary cell types.  The basis of 1.25(OH)2D3 effect 
on the immune system is represented by its impact on white 
blood cells growth and differentiation [1-5].  Many years ago 
it was established that the development of carential rickets is 
accompanied by a decreased immune response and a high 
rate of pulmonary diseases [6, 7].  Scientific evidence-based 
explanations of this phenomenon have started to be given 
only recently [8, 9, 10, 11-14].
Some studies have established that the number of 
hematopoietic stem cells in the bone marrow of vitamin D-
loaded and depleted rats was twice as low as in the vitamin 
D-deficient group [1].  These data suggest that vitamin D is 
essential for stem-cell differentiation during embryonic devel-
opment.  Vitamin D deficiency in chickens is manifested by a 
functional decrease in B and T lymphocytes and monocytes’ 
activity.  Protein 1.25(OH)2D3 receptors have been found in 
thymus lymphocytes [15], in pulmonary monocyte-mac-
rophage series cells [16], in bone marrow cells, in activated 
monocytes-macrophages and in lymphocytes.  1.25(OH)2D3 
regulates the proliferation, differentiation and function of 
myeloid cells through the VDR.
Extensive in vitro studies have analyzed the effects of 
1.25(OH)2D3 in human HL-60 leukemic cells.  These cells 
express a large number of receptors to 1.25(OH)2D3 (more 
than 4 000 copies in one cell).  It was proven that the hor-
mone stimulates rapid maturation of macrophages-like cells 
[17].  This process is accompanied by an inhibition of cell 
proliferation and by the amplification of phagocytic activ-
ity.  The stimulation of macrophages differentiation under 
the influence of 1.25(OH)2D3 is observed in vivo in rats [2]. 
1.25–dihydroxivitamin D3 increases the number of alveolar 
macrophages both by directly influencing the processes of 
precursor cells differentiation, and by stimulating the develop-
ment of splenic cells.  The cultures of splenic cells show that 
approximately 90% of cells 3 days after 1.25–dihydroxivitamin 
D3 administration transform into macrophages with a degree 
of maturation directly correlated to the hormone dose.
Aside from being target cells for 1.25(OH)2D3, mac-
rophages express 25(OH)D-1-hydroxylase activity.  Mac-
rophages from pulmonary alveoli in humans produce 3H 
– 1.25(OH)2D3 when cultivated with a 3H – 25OHD3 marked
substrate [4].  The activity of 1-hydroxylase increases rapidly 
under the influence of interferon and is in direct relation with 
its dose.  Both an increase in the number of macrophages and 
in their antibacterial function occur, representing an impor-
tant therapeutic factor.  This mechanism encountered locally 
in macrophages helps the 1.25(OH)2D3 enhance the human 
monocyte/macrophage capacity to inhibit the growth of tu-
berculosis mycobacteria in vitro [18].  In addition, activated 
T-lymphocytes from patients with tuberculosis contribute 
to the local production of 1.25-(OH)2D3 [19].  This explains 
in part the well-known examples of the beneficial effects of 
vitamin D3 in the treatment of tuberculosis as well as the 
hypercalcemia encountered in 10%-20% of the patients with 
tuberculosis or granulomatous diseases such as sarcoidosis.

ARTICOLE DE PROBLEMĂ, SINTEZĂ şI PRELEGERI
Interleukin 2, the production of which is controlled by 
1.25(OH)2D3, modulates the transformation of macrophages 
in mononuclear giant cells – osteoclasts [2].  This transforma-
tion is accompanied by the loss of receptors for 1.25(OH)2D3. 
Thus, the receptor disappears completely in the last stage of 
monocyte-macrophage-osteoclast cell line differentiation, and 
1.25(OH)2D3 looses its influence on osteoclasts [20].
1.25(OH)2D promotes the differentiation of hema-
topoietic and monocyte-macrophages cell lines.  The first 
experiments carried out in 1983-1984 have shown its po-
sitive effect on differentiation of promyelocytic leukemic 
cell lines (HL-60 line) into macrophage type cells.  These in 
vitro results have since been amply confirmed and extended 
to the identification of multiple effects on the normal lines 
of circulating monocytes-macrophages.  Thus, 1.25(OH)2D 
promotes monocytes differentiation into macrophages and 
the fusion of these cells to give rise to multinucleated cells. 
It controls the proliferation and recruitment of these cells in 
regulating lymphocyte and monocyte production of growth 
factors, such as IL-3 and GM-CSF.  Finally, it increases the 
ability of adhesion, phagocytosis, bactericidal activity and 
antitumoral cytotoxicity of these cells.
Inversely, 1.25(OH)2D appears to be able to play an 
immunosuppressive role.  It first decreases the ability of mo-
nocytes-macrophages to activate T cells.  This effect requires 
the presence of IL-4, and has at least three known effects. 
Vitamin D inhibits the differentiation and maturation of 
dendritic cells of a monocytic origin into antigen presenting 
cells.  It increases the ability of spontaneous mature cells apop-
tosis.  Finally, it decreases the expression of HLA class II and 
protein B7.2 molecules by these cells, a costimulator of major 
histocompatibility complexes recognition by T lymphocytes. 
It also decreases the secretion of IL-12 by antigen presenting 
cells, which is a Th1 cells activating cytokine.  These effects 
lead to the recruitment of less responding, less specific and 
less gamma-interferon secreting T cells.
1.25(OH)2D also directly acts on lymphocytes by de-
creasing the production of immunoglobulins by B cells, by 
reducing the proliferation of CD4+ and CD8+ T lymphocytes, 
by reducing the production and function of cytotoxic killer 
cells (“Natural Killer” NK, and Cytotoxic T lymphocytes, 
CTL), and by modulating the immunosuppressive activity 
of T lymphocytes.  In regards to T cells, its action is exerted 
preferentially on Th1 helper cells and mainly on their ability 
to secrete IL-2 and gamma-interferon, which decreases.
Chronic administration of 1.25(OH)2D and of some 
analogs decreases the level of circulating IL-2 and IgG immu-
noglobulins without modifying the number and repartition 
of circulating lymphocytes subtypes, or of leukocytes and 
platelets.
The clinical observations of an altered resistance to 
infectious disorders in carential rickets have been reported 
long before the modern conception of rickets physiopathology 
and vitamin D metabolites action was defined [18].  The main 
arguments are the increased receptivity to acute respiratory 
infections in breastfed infants with rickets, the permanent 
identification of pathological manifestations of rickets in 
children who have died within the first year of life, and the 
lower values of these indices if specific ante- and postnatal 
preventive measures with adequate doses of vitamin D have 
been undertaken.
Clinical epidemiology in frequently ill children from 
the Republic of Moldova has demonstrated the presence of 
rickets in all these children.  The majority of children with 
signs of rickets had frequent episodes of acute respiratory 
diseases and relapsing forms of pneumonia with a subacute 
evolution.  The description of the flourishing rickets includes 
data on a reduced resistance to infections, possible associa-
tion with carential anemia, as well as the notion of rachitic 
lung.  The term “rachitic lung” includes a group of anatomic 
and functional changes related to rickets, which aggravate 
dyspnea in respiratory pathologies following intrication of 
infectious and rachitic factors.  Rickets has a primordial me-
chanical action, impairing the respiratory dynamics, while the 
osseous factor (extreme softening of costal arches, with rib 
cupping and flaring, forming the “rachitic rosary”), as well as 
the muscular factor (rachitic muscular hypotony) impair the 
respiratory kinetics.  Rachitic bronchomalacia and reduced 
resistance to infections are additional pathological conditions 
characteristic of rachitic lung.  Vitamin D deficiency and 
hypocalcaemia are accompanied by a significant decrease in 
sialic acids level, which inhibit the neuraminidase of bacterial 
and viral agents; it is also manifested through an impaired 
monocyte/macrophage activity, phagocytosis, pinocytosis, 
membrane channels function following a reduced activity of 
3.5-cAMP [12, 13].
Thus 1.25-(OH)2D3 acts as one of the main regulators of 
calcium metabolism both at the cellular level and in the body 
as a whole, having a severe impact on an infant’s immune sys-
tem strengthening against infectious agents, and, specifically, 
against acute respiratory infections.
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